Alignment Healthcare, Inc. (ALHC) stock
ALHCNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3053% above fair value
$6.72−0.90 (-11.81%)
Close on Nov 18, 2026Market cap $1.41BP/E 61.1Yield –
Alignment Healthcare cash
Cash and short-term investments held at the end of each period.
Alignment Healthcare's cash was $742.95M at Sep 30, 2026. For fiscal 2025 it was $604.23M, up 27.8% from the year before. The highest annual figure on record is $604.23M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $604.23M | +27.8% |
| FY2024 | Dec 31, 2024 | $472.73M | +48.3% |
| FY2023 | Dec 31, 2023 | $318.82M | -22.5% |
| FY2022 | Dec 31, 2022 | $411.30M | -12.2% |
| FY2021 | Dec 31, 2021 | $468.35M | +125.4% |
| FY2020 | Dec 31, 2020 | $207.81M | +140.3% |
| FY2019 | Dec 31, 2019 | $86.48M | +148.2% |
| FY2018 | Dec 31, 2018 | $34.85M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $742.95M | +15.4% |
| Q2 FY2026 | Jun 30, 2026 | $701.71M | +39.3% |
| Q1 FY2026 | Mar 31, 2026 | $726.29M | +51.5% |
| Q4 FY2025 | Dec 31, 2025 | $604.23M | +27.8% |
| Q3 FY2025 | Sep 30, 2025 | $644.08M | +69.1% |
| Q2 FY2025 | Jun 30, 2025 | $503.78M | +38.5% |
| Q1 FY2025 | Mar 31, 2025 | $479.54M | +58.9% |
| Q4 FY2024 | Dec 31, 2024 | $472.73M | +48.3% |
| Q3 FY2024 | Sep 30, 2024 | $380.98M | -26.1% |
| Q2 FY2024 | Jun 30, 2024 | $363.71M | -29.7% |
| Q1 FY2024 | Mar 31, 2024 | $301.71M | -38.1% |
| Q4 FY2023 | Dec 31, 2023 | $318.82M | -22.5% |
| Q3 FY2023 | Sep 30, 2023 | $515.57M | -9.1% |
| Q2 FY2023 | Jun 30, 2023 | $517.51M | +14.2% |
| Q1 FY2023 | Mar 31, 2023 | $487.74M | +8.7% |
| Q4 FY2022 | Dec 31, 2022 | $411.30M | -12.2% |
| Q3 FY2022 | Sep 30, 2022 | $567.45M | +13.4% |
| Q2 FY2022 | Jun 30, 2022 | $453.23M | -8.4% |
| Q1 FY2022 | Mar 31, 2022 | $448.84M | -15.1% |
| Q4 FY2021 | Dec 31, 2021 | $468.35M | +125.4% |
| Q3 FY2021 | Sep 30, 2021 | $500.49M | +125.1% |
| Q2 FY2021 | Jun 30, 2021 | $494.62M | +146.2% |
| Q1 FY2021 | Mar 31, 2021 | $528.42M | +174.6% |
| Q4 FY2020 | Dec 31, 2020 | $207.81M | +140.3% |
| Q3 FY2020 | Sep 30, 2020 | $222.33M | +537.9% |
| Q2 FY2020 | Jun 30, 2020 | $200.88M | – |
| Q1 FY2020 | Mar 31, 2020 | $192.41M | – |
| Q4 FY2019 | Dec 31, 2019 | $86.48M | – |
| Q4 FY2018 | Dec 31, 2018 | $34.85M | – |
See a number that looks wrong?